No abstract available
MeSH terms
-
Carcinoma, Transitional Cell / drug therapy*
-
Carcinoma, Transitional Cell / pathology
-
Humans
-
Protein Kinase Inhibitors / therapeutic use*
-
Pyrazoles / therapeutic use*
-
Quinoxalines / therapeutic use*
-
Treatment Outcome
-
Urologic Neoplasms / drug therapy*
-
Urologic Neoplasms / pathology
-
Urothelium / pathology*
Substances
-
Protein Kinase Inhibitors
-
Pyrazoles
-
Quinoxalines
-
erdafitinib